Vanda Pharmaceuticals
VNDA
#8419
Rank
$0.30 B
Marketcap
$5.09
Share price
-1.55%
Change (1 day)
3.67%
Change (1 year)

Vanda Pharmaceuticals (VNDA) - Cash on Hand

Cash on Hand as of June 2026 : $0.17 Billion USD

According to Vanda Pharmaceuticals's latest financial reports the company has $0.17 Billion USD in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Vanda Pharmaceuticals - Cash on Hand chart (from 2005 to 2026)

Cash on Hand by year

Year Cash on Hand Change
2025-12-31$0.26 B-29.57%
2024-12-31$0.37 B-3.51%
2023-12-31$0.38 B-16.83%
2022-12-31$0.46 B7.87%
2021-12-31$0.43 B17.7%
2020-12-31$0.36 B17.82%
2019-12-31$0.31 B21.28%
2018-12-31$0.25 B79.45%
2017-12-31$0.14 B1.47%
2016-12-31$0.14 B-1.29%
2015-12-31$0.14 B10.29%
2014-12-31$0.12 B-0.41%
2013-12-31$0.13 B8.26%
2012-12-31$0.12 B-19.13%
2011-12-31$0.14 B-24.82%
2010-12-31$0.19 B-3.54%
2009-12-31$0.20 B341.89%
2008-12-31$46.45 M-45.45%
2007-12-31$85.17 M167.25%
2006-12-31$31.87 M2.3%
2005-12-31$31.15 M91.6%
2004-12-31$16.25 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Johnson & Johnson
JNJ
$20.75 B 12,108.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
$7.69 B 4,422.76%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
$11.69 B 6,780.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
$8.95 B 5,163.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
$7.14 B 4,099.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$11.06 B 6,408.89%๐Ÿ‡บ๐Ÿ‡ธ USA